Allogene Therapeutics Inc... (ALLO)
NASDAQ: ALLO
· Real-Time Price · USD
1.10
0.03 (2.80%)
At close: Aug 15, 2025, 3:59 PM
1.12
1.36%
After-hours: Aug 15, 2025, 07:51 PM EDT
Allogene Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -50.94M | -59.73M | -59.94M | -66.29M | -66.36M | -65M | -89.26M | -61.31M | -77.99M | -98.7M | -94.85M | -83.15M | -74.79M | -79.85M | -74.87M | -78.19M | -70.94M | -33.02M |
Depreciation & Amortization | 3.11M | 3.1M | 3.23M | 3.21M | 3.64M | 3.56M | 3.48M | 3.57M | 3.64M | 3.51M | 3.07M | 3.86M | 3.67M | 3.69M | 4.24M | 2.33M | 1.96M | 1.92M |
Stock-Based Compensation | 8.69M | 12.18M | 12.87M | 13.39M | 13.56M | 11.92M | 15.23M | 15.35M | 16.59M | 18.77M | 17.25M | 21.15M | 22.89M | 22.32M | 22.04M | 20.86M | 21.13M | 16.79M |
Other Working Capital | 7.96M | -7.96M | 5.24M | 28.42M | -23.56M | -4.32M | -3.1M | -10.92M | -105K | 6.32M | 7.87M | 53K | 3.68M | -19.49M | 1.94M | 3.18M | 6.98M | -43.42M |
Other Non-Cash Items | -8.17M | -176K | 1.86M | -15.61M | 2.32M | -1.94M | 75K | 147K | 150K | 2.41M | 6.96M | 553K | 591K | 5.6M | -11K | 228K | 387K | 2.01M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | 20.17M | 1.6M | 140K | n/a | -5.33M | n/a | n/a | n/a | 3.27M | 2.52M | 2.37M | 2.24M |
Change in Working Capital | 8.29M | -8.29M | 5.27M | 21.19M | -16.75M | -4.44M | -3.4M | -14.89M | -4.39M | 7.38M | 10.81M | 7.79M | 5.1M | -19.99M | -107K | 3.37M | 3.91M | -39.27M |
Operating Cash Flow | -39.03M | -52.93M | -36.7M | -44.12M | -63.59M | -55.9M | -53.71M | -55.53M | -61.86M | -66.64M | -62.1M | -47.66M | -42.53M | -68.24M | -45.44M | -48.88M | -41.17M | -49.33M |
Capital Expenditures | -44K | -99K | -257K | -429K | n/a | -8K | -181K | -12K | -288K | -1.03M | -1.69M | -223K | -1.37M | -1.9M | -736K | -3.35M | -10.9M | -6.46M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | -67.64M | 34.26M | -17.45M | -113.97M | -51.29M | n/a | -55.41M | n/a | -1.77M | n/a | n/a | -15.94M |
Purchase of Investments | -9.92M | -50.23M | -46.97M | -190.76M | -42.61M | -81.13M | -68.7M | -199.41M | -135.42M | -35.09M | -47.79M | -49.45M | -61.71M | -89.16M | -50.78M | -145.41M | -180.34M | -149.05M |
Sales Maturities Of Investments | 53.8M | 56.5M | 102.17M | 115.2M | 117.22M | 103.27M | 136.34M | 165.16M | 152.87M | 149.06M | 99.08M | 74.58M | 117.12M | 68.68M | 82.54M | 161.77M | 215.83M | 268.25M |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | 67.64M | -34.26M | 17.45M | 113.97M | 51.29M | 25.13M | 55.41M | -20.48M | 29.99M | 16.36M | 35.5M | 103.26M |
Investing Cash Flow | 43.84M | 6.18M | 54.93M | -75.99M | 74.61M | 22.13M | 67.46M | -34.27M | 17.16M | 112.94M | 49.6M | 24.91M | 54.03M | -22.38M | 29.25M | 13.01M | 24.59M | 96.8M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | 638K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.73M | 2.46M | n/a | n/a | 1.53M | 3.62M | n/a | n/a | 1.98M |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 5.07M | 3.99M | n/a | n/a | 2.3M | n/a | n/a | 1.09M | 89.52M | 1.73M | 46K | 1.07M | 24K | 1.81M | 322K | 2.38M | 3.21M | 6.04M |
Financial Cash Flow | 5.07M | 13.99M | 5.74M | 679K | 108.6M | 1.65M | 155K | 4.29M | 89.52M | 1.73M | 46K | 1.07M | 24K | 1.81M | 322K | 2.38M | 3.21M | 6.04M |
Net Cash Flow | 9.88M | -32.76M | 23.98M | -119.43M | 119.63M | -32.12M | 13.91M | -85.51M | 44.83M | 48.03M | -12.45M | -21.68M | 11.53M | -88.8M | -15.86M | -33.48M | -13.36M | 53.51M |
Free Cash Flow | -39.07M | -53.03M | -36.95M | -44.54M | -63.59M | -55.91M | -53.89M | -55.54M | -62.15M | -67.67M | -63.79M | -47.88M | -43.91M | -70.14M | -46.17M | -52.23M | -52.07M | -55.79M |